FDA Inspection 743696 — Innovative Blood Resources, A Division Of New York Blood Center, Inc.

Innovative Blood Resources, A Division Of New York Blood Center, Inc. — FEI 1970753

The FDA completed an inspection of Innovative Blood Resources, A Division Of New York Blood Center, Inc. on Sep 2, 2011 in Lincoln, NE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 2, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lincoln, NE (United States)

Citations

IDCFRDescription
9821 CFR 606.100(c)Thorough investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.